Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J RIVERA

Showing results (821-830 of 835) with videos related to

Pageof 84
Sort By:
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Adjuvant interventions in the treatment of precocious puberty: Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Jessie N Zurita-Cruz, Blanca E Aguilar-Herrera, et al.
Journal of Medicinal Chemistry|July 3, 2019
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[<i>d</i>]thiazol-5-ylamino)-6-(<i>tert</i>-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory DiseasesPamela A Haile, Linda N Casillas, Bartholomew J Votta, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Diagnosis of secondary causes of precocious puberty: Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Raúl Calzada-León, Aleida J Rivera-Hernández, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Synthesis of the evidence: Clinical guideline for the diagnosis and treatment of precocious pubertyM Fernanda Castilla-Peón, Margarita Torres-Tamayo, Jessie N Zurita-Cruz, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.
ACS Medicinal Chemistry Letters|October 23, 2018
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.
Revista De Gastroenterologia De Mexico (English)|October 8, 2018
Prevalence of eosinophilic esophagitis: A multicenter study on a pediatric population evaluated at thirty-six Latin American gastroenterology centersR Pierre, M Vieira, R Vázquez, et al.
Journal of Medicinal Chemistry|February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory DiseasesPhilip A Harris, Scott B Berger, Jae U Jeong, et al.
Georgian Medical News|November 25, 2022
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURASH Ramos-Zaldívar, K Reyes-Perdomo, N Espinoza-Moreno, et al.
Solar Physics|June 16, 2023
Defining the Middle CoronaMatthew J West, Daniel B Seaton, David B Wexler, et al.
Pageof 84

Showing results (821-830 of 835) with videos related to

Sort By:
Pageof 84
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Adjuvant interventions in the treatment of precocious puberty: Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Jessie N Zurita-Cruz, Blanca E Aguilar-Herrera, et al.
Journal of Medicinal Chemistry|July 3, 2019
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[<i>d</i>]thiazol-5-ylamino)-6-(<i>tert</i>-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory DiseasesPamela A Haile, Linda N Casillas, Bartholomew J Votta, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Diagnosis of secondary causes of precocious puberty: Clinical guideline for the diagnosis and treatment of precocious pubertyMargarita Torres-Tamayo, Raúl Calzada-León, Aleida J Rivera-Hernández, et al.
Boletin Medico Del Hospital Infantil De Mexico|July 3, 2020
Synthesis of the evidence: Clinical guideline for the diagnosis and treatment of precocious pubertyM Fernanda Castilla-Peón, Margarita Torres-Tamayo, Jessie N Zurita-Cruz, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.
ACS Medicinal Chemistry Letters|October 23, 2018
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.
Revista De Gastroenterologia De Mexico (English)|October 8, 2018
Prevalence of eosinophilic esophagitis: A multicenter study on a pediatric population evaluated at thirty-six Latin American gastroenterology centersR Pierre, M Vieira, R Vázquez, et al.
Journal of Medicinal Chemistry|February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory DiseasesPhilip A Harris, Scott B Berger, Jae U Jeong, et al.
Georgian Medical News|November 25, 2022
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURASH Ramos-Zaldívar, K Reyes-Perdomo, N Espinoza-Moreno, et al.
Solar Physics|June 16, 2023
Defining the Middle CoronaMatthew J West, Daniel B Seaton, David B Wexler, et al.
Pageof 84